Audrey Di Giorgio Selected Research

panicein A

6/2020

Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Audrey Di Giorgio Research Topics

Disease

11	Neoplasms (Cancer) 10/2023 - 09/2015
2	Adenocarcinoma 01/2018 - 04/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 04/2016
1	Carcinogenesis 10/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2022
1	Virus Diseases (Viral Diseases) 11/2022
1	Melanoma (Melanoma, Malignant) 06/2020
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2019
1	Carcinoma (Carcinomatosis) 01/2018

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 10/2023 - 09/2015
3	RNA (Ribonucleic Acid)IBA 11/2022 - 09/2015
2	LigandsIBA 03/2022 - 09/2015
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	panicein AIBA 06/2020
1	VemurafenibIBA 06/2020
1	hydroquinone (Esoterica)FDA Link 06/2020
1	Type 2 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	Neomycin FDA LinkGeneric 01/2018
1	Histidine (L-Histidine)FDA Link 01/2018
1	AminoglycosidesIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Staphylococcal Protein A (Protein A)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Ribonuclease III (RNase III)IBA 04/2016

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2016
2	Drug Therapy (Chemotherapy) 10/2023 - 01/2021
1	Immunotherapy 01/2021